Appointment coincides with approval to sell Super CitriMax® in Australia
Benicia, Calif., June 21, 2006 – InterHealth Nutraceuticals, Inc. today announced the appointment of Pathway International Pty Ltd as its exclusive distributor for the Australian and New Zealand markets.
In line with InterHealth’s corporate objective to expand its business and brands globally, this appointment coincides with the company’s ability to sell its weight-loss product, Super CitriMax®, in Australia. The country’s Therapeutic Goods Administration (TGA) recently approved use of Garcinia zeylanica (sometimes called Garcinia cambogia), a South Asian fruit used to produce Super CitriMax®. InterHealth’s patented, all-natural Super CitriMax® is the only product derived from Garcinia zeylanica extract that is clinically proven to boost serotonin levels and decrease body weight 3-times greater than diet and exercise alone.
“The appointment of an exclusive distributor of Pathway’s caliber will greatly enhance our distribution efforts in the Australian and New Zealand market,” said Darryl Mircheff, Vice President of International Sales for InterHealth. “Given our increased presence in the international arena and a goal of providing our customers with the best support possible, channeling our sales through one strategic business partner in this market will be very beneficial,” Mircheff added.
Pathway International, which is based in Sydney, Australia, has a team with many years of experience in pharmaceuticals, OTCs, supplements and regulatory issues, which makes the company the logical choice for InterHealth.
“With the growing obesity epidemic and an aging population, InterHealth plans to bring more products to market through Pathway as these products are developed and packaged for approval through the appropriate regulatory channels,” Mircheff said. These branded products include ChromeMate®, a patented oxygen-coordinated niacin-bound chromium supplement that increases the effectiveness of chromium, an essential element for proper insulin function; L-OptiZinc®, a patented form of methionine-bound zinc, an essential trace mineral that promotes immune health and serves as a powerful antioxidant; and UC-II®, a patented all-natural, safe and effective dietary ingredient consisting of undenatured type II collagen that helps promote healthy joints and increase joint mobility and flexibility.
“We believe that the product mix from InterHealth complements the Pathway offering,” said Wayne Coote, Managing Director for Pathway, “and feel confident that this new relationship will help both InterHealth and Pathway further develop their business in Australia and New Zealand.”
# # #
About InterHealth Nutraceuticals Inc.
InterHealth Nutraceuticals researches, develops, markets and distributes specialty nutritional ingredients, which are sold worldwide to manufacturers of dietary supplements and nutraceutical food and beverage products. For more information about InterHealth and its products, call 1-800-783-4636 or 1-707-751-2800 (outside U.S) or visit the website at www.interhealthusa.com.
About Pathway International Pty Ltd.
Pathway is the exclusive distributor in Australia and New Zealand for leading suppliers of high quality and innovative ingredients that add value to the health care and nutrition industries.